ENTITY
Hansoh Pharmaceutical

Hansoh Pharmaceutical (3692 HK)

400
Analysis
Health Care • China
Hansoh Pharmaceutical is a pharmaceutical company that researches, develops, manufactures, and sells a diverse portfolio of medicines. It focuses on therapeutic areas such as oncology, anti-infectives, central nervous system diseases, metabolic disorders, and autoimmune diseases. The company was founded in 1995 and is headquartered in Shanghai, China.
more
•24 May 2026 10:10

HK Short Interest Weekly: Tencent, Yofc, Midea, AIA, Weichai Power, Time Interconnect Technology

We analyzed the latest HK SFC report for aggregate short position as of May 15th and highlight short interest changes in Tencent (700 HK), Yofc...

Logo
129 Views
Share
bullish•Wuxi Biologics
•22 May 2026 10:45

HSCEI May 2026 Index Review Forecast

HSCEI May 2026 rebalance announcement due after market close today: a good time to revisit our review forecast as the decision approaches.

Logo
416 Views
Share
•17 May 2026 10:10

HK Short Interest Weekly: Tencent, Bidu, CATL, Midea, Meituan, Anta

We analyzed the latest HK SFC report for aggregate short position as of May 8th and highlight short interest changes in Tencent, Bidu, CATL, Midea,...

Logo
102 Views
Share
bullish•MiniMax
•12 May 2026 09:15

MiniMax-W: Index Events Reassessed

We analyze Minimax's upcoming index event and reassess the possibility of its HSI entry. HS TECH and HSCI enter in June; HSI is deferred until the...

Logo
434 Views
Share
•07 May 2026 10:48

Aequitas: Suzhou TFC Optical Communication A/H Listing - Rising Sales, Steady Margins

Suzhou Tfc Optical (300394 CH) (STFC), an optical interconnect solutions provider, aims to raise around US$2bn in its H-share listing. In this...

Logo
244 Views
Share
x